4.6 Article

Hierarchical Hydrogels with Ordered Micro-Nano Structures for Cancer-on-a-Chip Construction

Journal

RESEARCH
Volume 2021, Issue -, Pages -

Publisher

AMER ASSOC ADVANCEMENT SCIENCE
DOI: 10.34133/2021/9845679

Keywords

-

Funding

  1. National Key Research and Development Program of China [2020YFA0908200]
  2. Strategic Priority Research Program of the Chinese Acad-emy of Science [XDA16021103]
  3. National Natural Science Foundation of China [52073060, 61927805]
  4. Shenzhen Fundamental Research Program [JCYJ20190813152616459]

Ask authors/readers for more resources

Inspired by the microstructures of hepatic lobules, researchers developed a hierarchical hydrogel system for liver cancer-on-a-chip construction and drug screening, achieving precise control of cell spheroid size and adequate nutrient supply. This technology shows great potential in the field of personalized medicine.
In the drug therapy of tumor, efficient and stable drug screening platforms are required since the drug efficacy varies individually. Here, inspired by the microstructures of hepatic lobules, in which hepatocytes obtain nutrients from both capillary vessel and the central vein, we present a novel hierarchical hydrogel system with ordered micro-nano structure for liver cancer-on-a-chip construction and drug screening. The hierarchical hydrogel system was fabricated by using pregel to fill and replicate selfassembled colloidal crystal arrays and microcolumn array template. Due to the synergistic effect of its interconnected micro-nano structures, the resultant system could not only precisely control the size of cell spheroids but also realize adequate nutrient supply of cell spheroids. We have demonstrated that by integrating the hierarchical hydrogel system into a multichannel concentration gradients microfluidic chip, a functional liver cancer-on-a-chip could be constructed for high-throughput drug screening with good repeatability and high accuracy. These results indicated that the hierarchical hydrogel system and its derived liver cancer-on-a-chip are ideal platforms for drug screening and have great application potential in the field of personalized medicine.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available